Indication
Psychosis associated with Parkinson's disease
Psychosis associated with Parkinson's disease is a neuropsychiatric complication affecting the central nervous system in individuals diagnosed with Parkinson's disease, typically emerging in more advanced stages of the illness. Read more about Psychosis associated with Parkinson's disease
2 drugs 1 manufacturers
Drugs that treat it
Common Psychosis associated with Parkinson's disease therapies.
NUPLAZID (pimavanserin tartrate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPsychosis associated with Parkinson's disease is a neuropsychiatric complication affecting the central nervous system in individuals diagnosed with Parkinson's disease, typically emerging in more advanced stages of the illness.
It is clinically characterized by a spectrum of perceptual disturbances, most prominently vivid visual hallucinations, passage or presence phenomena, and persecutory or paranoid delusions, which frequently occur in the context of a clear sensorium.
Pathophysiologically, the condition arises from a complex interaction between progressive neurodegeneration—involving Lewy body pathology, visual-processing circuitry deficits, and imbalances in serotonergic, cholinergic, and dopaminergic neurotransmission—and the chronic use of dopaminergic pharmacotherapies.
- nih.gov
Psychosis associated with Parkinson's disease is a neuropsychiatric complication affecting the central nervous system in individuals diagnosed with Parkinson's disease, typically emerging in more advanced stages of the illness It is clinically characterized by a spectrum of perceptual disturbances, most prominently vivid visual hallucinations, passage or presence phenomena, and persecutory or paranoid delusions, which frequently occur in the context of a clear sensorium
- nih.gov
Psychosis associated with Parkinson's disease is a neuropsychiatric complication affecting the central nervous system in individuals diagnosed with Parkinson's disease, typically emerging in more advanced stages of the illness It is clinically characterized by a spectrum of perceptual disturbances, most prominently vivid visual hallucinations, passage or presence phenomena, and persecutory or paranoid delusions, which frequently occur in the context of a clear sensorium Pathophysiologically, the...
- nih.gov
Psychosis associated with Parkinson's disease is a neuropsychiatric complication affecting the central nervous system in individuals diagnosed with Parkinson's disease, typically emerging in more advanced stages of the illness
- nih.gov
It is clinically characterized by a spectrum of perceptual disturbances, most prominently vivid visual hallucinations, passage or presence phenomena, and persecutory or paranoid delusions, which frequently occur in the context of a clear sensorium
- nih.gov
It is clinically characterized by a spectrum of perceptual disturbances, most prominently vivid visual hallucinations, passage or presence phenomena, and persecutory or paranoid delusions, which frequently occur in the context of a clear sensorium
- nih.gov
Pathophysiologically, the condition arises from a complex interaction between progressive neurodegeneration—involving Lewy body pathology, visual-processing circuitry deficits, and imbalances in serotonergic, cholinergic, and dopaminergic neurotransmission—and the chronic use of dopaminergic pharmacotherapies
Personalize your experience
Follow Psychosis associated with Parkinson's disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.